Methylphenidate in ADDH and Epilepsy

Abstract

The safety of methylphenidate (MPH), 0.3 mg/kg, in 9 boys and 8 girls, ages 6 to 16 years, with ADHD and epilepsy, studied in Jerusalem, Israel, was reported at the Annual Meeting of the Child Neurology Society, Oct 2-8, 1994, in San Francisco, CA.

Keywords

• methylphenidate
• mderate exacerbation
• adhd symptoms